ANNIE SUAREZ BAS: Open Payments
NPI 1023580404 · TAMARAC, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,766 in 67 payments from 15 companies in 2025. Trend: 2023 $1,016 · 2024 $1,462 · 2025 $1,766
Food & beverage: $1,766
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $444 |
| E.R. Squibb & Sons, L.L.C. | 35 | $435 |
| Edwards Lifesciences Corporation | 1 | $212 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $144 |
| AstraZeneca Pharmaceuticals LP | 1 | $135 |
| Boston Scientific Corporation | 3 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $75 |
| PFIZER INC. | 3 | $61 |
| Amgen Inc. | 2 | $39 |
| Alnylam Pharmaceuticals Inc. | 1 | $34 |
Products named: CAMZYOS, Wegovy, Ozempic, ELIQUIS, Kerendia, LOKELMA, WATCHMAN FLX, JARDIANCE.
Industry payments across FL — which companies pay providers there.
